chr22-19760999-C-CCCG

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001379200.1(TBX1):​c.170_172dupCGC​(p.Pro57dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000717 in 933,994 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000082 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000070 ( 0 hom. )

Consequence

TBX1
NM_001379200.1 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 1.41

Publications

0 publications found
Variant links:
Genes affected
TBX1 (HGNC:11592): (T-box transcription factor 1) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene product shares 98% amino acid sequence identity with the mouse ortholog. DiGeorge syndrome (DGS)/velocardiofacial syndrome (VCFS), a common congenital disorder characterized by neural-crest-related developmental defects, has been associated with deletions of chromosome 22q11.2, where this gene has been mapped. Studies using mouse models of DiGeorge syndrome suggest a major role for this gene in the molecular etiology of DGS/VCFS. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
TBX1 Gene-Disease associations (from GenCC):
  • conotruncal heart malformations
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • DiGeorge syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • velocardiofacial syndrome
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • 22q11.2 deletion syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001379200.1
BP6
Variant 22-19760999-C-CCCG is Benign according to our data. Variant chr22-19760999-C-CCCG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 263404.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000825 (12/145488) while in subpopulation SAS AF = 0.000209 (1/4784). AF 95% confidence interval is 0.0000493. There are 0 homozygotes in GnomAd4. There are 9 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TBX1NM_001379200.1 linkc.170_172dupCGC p.Pro57dup disruptive_inframe_insertion Exon 1 of 7 ENST00000649276.2 NP_001366129.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TBX1ENST00000649276.2 linkc.170_172dupCGC p.Pro57dup disruptive_inframe_insertion Exon 1 of 7 NM_001379200.1 ENSP00000497003.1 A0A3B3IS18

Frequencies

GnomAD3 genomes
AF:
0.0000825
AC:
12
AN:
145488
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000246
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000136
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000201
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000107
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000698
AC:
55
AN:
788506
Hom.:
0
Cov.:
11
AF XY:
0.0000630
AC XY:
23
AN XY:
365226
show subpopulations
African (AFR)
AF:
0.000135
AC:
2
AN:
14846
American (AMR)
AF:
0.00
AC:
0
AN:
932
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
4876
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3358
South Asian (SAS)
AF:
0.000183
AC:
3
AN:
16374
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
262
Middle Eastern (MID)
AF:
0.000644
AC:
1
AN:
1552
European-Non Finnish (NFE)
AF:
0.0000652
AC:
47
AN:
720538
Other (OTH)
AF:
0.0000776
AC:
2
AN:
25768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000825
AC:
12
AN:
145488
Hom.:
0
Cov.:
31
AF XY:
0.000127
AC XY:
9
AN XY:
70692
show subpopulations
African (AFR)
AF:
0.0000246
AC:
1
AN:
40636
American (AMR)
AF:
0.000136
AC:
2
AN:
14678
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3380
East Asian (EAS)
AF:
0.000201
AC:
1
AN:
4970
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4784
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8282
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
298
European-Non Finnish (NFE)
AF:
0.000107
AC:
7
AN:
65558
Other (OTH)
AF:
0.00
AC:
0
AN:
1998
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.529
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Sep 26, 2012
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

There is insufficient or conflicting evidence for classification of this alteration. -

DiGeorge syndrome Benign:1
Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.4
Mutation Taster
=87/13
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs886038791; hg19: chr22-19748522; API